Annual Cash & Cash Equivalents
$13.35 M
-$20.64 M-60.73%
December 31, 2022
Summary
- As of February 10, 2025, CYAD annual cash & cash equivalents is $13.35 million, with the most recent change of -$20.64 million (-60.73%) on December 31, 2022.
- During the last 3 years, CYAD annual cash & cash equivalents has fallen by -$30.72 million (-69.71%).
Performance
CYAD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.03 M
-$7.87 M-34.37%
June 30, 2022
Summary
- As of February 10, 2025, CYAD quarterly cash and cash equivalents is $15.03 million, with the most recent change of -$7.87 million (-34.37%) on June 30, 2022.
- Over the past year, CYAD quarterly cash and cash equivalents has increased by +$725.80 thousand (+5.08%).
Performance
CYAD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CYAD Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -60.7% | +5.1% |
3 y3 years | -69.7% | -60.8% |
5 y5 years | -52.2% | -44.0% |
CYAD Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -60.7% | at low | -55.8% | at low |
5 y | 5-year | -69.7% | at low | -65.9% | -52.9% |
alltime | all time | -87.8% | -83.7% | -88.5% | -85.5% |
Celyad Oncology SA Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $13.35 M(-60.7%) | - |
Jun 2022 | - | $15.03 M(-34.4%) |
Mar 2022 | - | $22.89 M(-32.6%) |
Dec 2021 | $33.99 M(+60.3%) | $33.99 M(+380.5%) |
Sep 2021 | - | $7.07 M(-50.5%) |
Jun 2021 | - | $14.30 M(+0.5%) |
Mar 2021 | - | $14.22 M(-32.9%) |
Dec 2020 | $21.20 M(-51.9%) | $21.20 M(-29.4%) |
Jun 2020 | - | $30.02 M(-31.9%) |
Dec 2019 | $44.07 M(-5.0%) | $44.07 M(+15.1%) |
Jun 2019 | - | $38.28 M(-17.5%) |
Dec 2018 | $46.38 M | $46.38 M(-35.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2018 | - | $72.13 M(+158.6%) |
Dec 2017 | $27.90 M(-45.4%) | $27.90 M(+4.0%) |
Jun 2017 | - | $26.82 M(-47.5%) |
Dec 2016 | $51.12 M(-53.3%) | $51.12 M(-14.4%) |
Jun 2016 | - | $59.72 M(-45.5%) |
Dec 2015 | $109.52 M(+225.9%) | $109.52 M(-15.9%) |
Jun 2015 | - | $130.24 M(+287.6%) |
Dec 2014 | $33.60 M(+27.7%) | $33.60 M(-29.8%) |
Jun 2014 | - | $47.85 M(+81.8%) |
Dec 2013 | $26.32 M(+1109.6%) | $26.32 M(+412.1%) |
Jun 2013 | - | $5.14 M(+136.2%) |
Dec 2012 | $2.18 M | $2.18 M |
FAQ
- What is Celyad Oncology SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Celyad Oncology SA?
- What is Celyad Oncology SA annual cash & cash equivalents year-on-year change?
- What is Celyad Oncology SA quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Celyad Oncology SA?
- What is Celyad Oncology SA quarterly cash and cash equivalents year-on-year change?
What is Celyad Oncology SA annual cash & cash equivalents?
The current annual cash & cash equivalents of CYAD is $13.35 M
What is the all time high annual cash & cash equivalents for Celyad Oncology SA?
Celyad Oncology SA all-time high annual cash & cash equivalents is $109.52 M
What is Celyad Oncology SA annual cash & cash equivalents year-on-year change?
Over the past year, CYAD annual cash & cash equivalents has changed by -$20.64 M (-60.73%)
What is Celyad Oncology SA quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CYAD is $15.03 M
What is the all time high quarterly cash and cash equivalents for Celyad Oncology SA?
Celyad Oncology SA all-time high quarterly cash and cash equivalents is $130.24 M
What is Celyad Oncology SA quarterly cash and cash equivalents year-on-year change?
Over the past year, CYAD quarterly cash and cash equivalents has changed by +$725.80 K (+5.08%)